The most specific immunohistological marker used in diagnosing retroperitoneal Ewing sarcoma is NKX2.2, while CD99 and FLI1 may serve as supporting markers in confirming the diagnosis [12]. This evidence concerns the gene CD99 and Ewing sarcoma.